Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab von Swain, S.M., Schneeweiss, A., Gianni, L., Gao, J.J., Stein, A., Waldron-Lynch, M., Heeson, S., Beattie, M.S., Yoo, B., Cortes, J., Baselga, J.

Volltext

Effect of docetaxel duration on clinical outcomes: exploratory analysis of CLEOPATRA, a phase III randomized controlled trial von Miles, D., Im, Y.-H., Fung, A., Yoo, B., Knott, A., Heeson, S., Beattie, M.S., Swain, S.M.

Volltext

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab von Swain, S M, Schneeweiss, A, Gianni, L, Gao, J J, Stein, A, Waldron-Lynch, M, Heeson, S, Beattie, M S, Yoo, B, Cortes, J, Baselga, J

Volltext

Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab von Swain, S.M., Schneeweiss, A., Gianni, L., Gao, J.J., Stein, A., Waldron-Lynch, M., Heeson, S., Beattie, M.S., Yoo, B., Cortes, J., Baselga, J.

Volltext

Interaction between differentially methylated regions partitions the imprinted genes Igf2 and H19 into parent-specific chromatin loops von Murrell, Adele, Reik, Wolf, Heeson, Sarah

Volltext

138P Anaphylaxis and hypersensitivity in trials of intravenous pertuzumab + trastuzumab (PH IV) or the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injecti... von Swain, S.M., Tan, A., Gianni, L., Kümmel, S., Dang, C., Schneeweiss, A., O'Shaughnessy, J., Liu, H., Aguila, C., Heeson, S., Macharia, H., Restuccia, E., Loibl, S.

Volltext

1423MO End-of-study analysis from JACOB: A phase III study of pertuzumab (P) + trastuzumab (H) and chemotherapy (CT) in HER2-positive metastatic gastric or gastro-esophageal juncti... von Tabernero, J., Hoff, P.M., Shen, L., Ohtsu, A., Shah, M.A., Siddiqui, A., Heeson, S., Wu, H., Restuccia, E., Kang, Y-K.

Volltext

46P Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection (PH FDC SC) plus chemotherapy in HER2-positive early breast cancer (EBC): Safety results from th... von Im, S-A., Tan, A.R., Mattar, A., Colomer, R., Stroyakovskii, D., Nowecki, Z., De Laurentiis, M., Pierga, J-Y., Jung, K.H., Schem, C., Aguila, C., Badovinac Crnjevic, T., Heeson, S., Shivhare, M., Alexandrou, A., Restuccia, E., Jackisch, C.

Volltext

Correction to: Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab von Swain, S.M., Schneeweiss, A., Gianni, L., Gao, J.J., Stein, A., Waldron-Lynch, M., Heeson, S., Beattie, M.S., Yoo, B., Cortes, J., Baselga, J.

Volltext

Abstract P4-14-27: Effect of docetaxel duration on clinical outcomes: Results from the phase III trial CLEOPATRA von Miles, D, Fung, A, Yoo, B, Knott, A, Heeson, S, Portera, C, Swain, S

Volltext

Abstract P5-20-07: A phase Ib dose-finding study of subcutaneous pertuzumab in combination with subcutaneous trastuzumab in healthy male volunteers and female patients with early b... von Kirschbrown, WP, Wynne, C, Kagedal, M, Wada, R, Li, H, Nijem, I, Badovinac Crnjevic, T, Heeson, S, Eng-Wong, J, Garg, A

Volltext

Abstract P4-14-14: Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab von Swain, SM, Schneeweiss, A, Gianni, L, Stein, A, McNally, V, Heeson, S, Portera, C, Yoo, B, Cortes, JC, Baselga, J

Volltext

An association between variants in the IGF2 gene and Beckwith–Wiedemann syndrome: interaction between genotype and epigenotype von Murrell, Adele, Heeson, Sarah, Cooper, Wendy N., Douglas, Eleanor, Apostolidou, Sophia, Moore, Gudrun E., Maher, Eamonn R., Reik, Wolf

Volltext

350O_PRFINAL OVERALL SURVIVAL (OS) ANALYSIS FROM THE CLEOPATRA STUDY OF FIRST-LINE (1L) PERTUZUMAB (PTZ), TRASTUZUMAB (T), AND DOCETAXEL (D) IN PATIENTS (PTS) WITH HER2-POSITIVE ME... von Swain, S., Kim, S., Cortes, J., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J., Schneeweiss, A., Heeson, S., Clark, E., Ross, G., Benyunes, M.C., Baselga, J.

Volltext

Final Overall Survival (Os) Analysis from the Cleopatra Study of First-Line (1L) Pertuzumab (Ptz), Trastuzumab (T), and Docetaxel (D) in Patients (Pts) with Her2-Positive Metastati... von Swain, S., Kim, S., Cortes, J., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J., Schneeweiss, A., Heeson, S., Clark, E., Ross, G., Benyunes, M.C., Baselga, J.

Volltext

An intragenic methylated region in the imprinted Igf2 gene augments transcription von Murrell, Adele, Heeson, Sarah, Bowden, Lucy, Constância, Miguel, Dean, Wendy, Kelsey, Gavin, Reik, Wolf

Volltext

Effect of docetaxel duration on clinical outcomes: exploratory analysis of CLEOPATRA, a phase III randomized controlled trial von Miles, D, Im, Y-H, Fung, A, Yoo, B, Knott, A, Heeson, S, Beattie, M S, Swain, S M

Volltext

Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer von Swain, Sandra M, Baselga, José, Kim, Sung-Bae, Ro, Jungsil, Semiglazov, Vladimir, Campone, Mario, Ciruelos, Eva, Ferrero, Jean-Marc, Schneeweiss, Andreas, Heeson, Sarah, Clark, Emma, Ross, Graham, Benyunes, Mark C, Cortés, Javier

Volltext

Pertuzumab, trastuzumab, and chemotherapy in HER2-positive gastric/gastroesophageal junction cancer: end-of-study analysis of the JACOB phase III randomized clinical trial von Tabernero, Josep, Hoff, Paulo M., Shen, Lin, Ohtsu, Atsushi, Shah, Manish A., Siddiqui, Asna, Heeson, Sarah, Kiermaier, Astrid, Macharia, Harrison, Restuccia, Eleonora, Kang, Yoon-Koo

Volltext

Usage, engagement and impact: evaluating the usage of and measuring impact and engagement with library resources at Leeds Beckett University Library von Cleverley, Julie, Heeson, Samantha

Volltext